Loading…

Regional brain uptake of the muscarinic ligand, [ 18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice

A muscarinic receptor radioligand, 3-(3-(3-fluoropropyl)thio) -1,2,5,thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine (fP-TZTP) radiolabeled with the positron emitting radionuclide 18F ([ 18F]FP-TZTP) displayed regional brain distribution consistent with M2 receptor densities in rat brain. The p...

Full description

Saved in:
Bibliographic Details
Published in:Neuropharmacology 2003-04, Vol.44 (5), p.653-661
Main Authors: Jagoda, E.M., Kiesewetter, D.O., Shimoji, K., Ravasi, L., Yamada, M., Gomeza, J., Wess, J., Eckelman, W.C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A muscarinic receptor radioligand, 3-(3-(3-fluoropropyl)thio) -1,2,5,thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine (fP-TZTP) radiolabeled with the positron emitting radionuclide 18F ([ 18F]FP-TZTP) displayed regional brain distribution consistent with M2 receptor densities in rat brain. The purpose of the present study is to further elucidate the subtype selectivity of [ 18F]FP-TZTP using genetically engineered mice which lacked functional M1, M2, M3, or M4 muscarinic receptors. Using ex vivo autoradiography, the regional brain localization of [ 18F]FP-TZTP in M2 knockout (M2 KO) was significantly decreased (51.3 to 61.4%; P
ISSN:0028-3908
1873-7064
DOI:10.1016/S0028-3908(03)00050-9